Marijuana Stocks Weather The Storm, Light At The End Of The Tunnel

Marijuana Stocks Weather The Storm, Light At The End Of The Tunnel


The marijuana industry couldn’t catch a break a few weeks back. First there were comments made by Sean Spicer and his opinion of what the administration thought about legalized marijuana, then there were Jeff Sessions’ statements on his dislike for the drug. But now that investors have seen a bit of the light, now could be the time to be paying attention to cannabis again.

If there’s one thing to investors like to looks for, it’s discounts and though psychology would suggest that when prices are high, investors wish they “could have gotten in when,” similarly, when prices are low, some think, “well I’m glad I didn’t get in when.”

With the marijuana sector in particular, not only has it been very cyclical but it has also been very much a speculation driven market. Now that things have settled a bit, I think it’s time to start looking at this market again because there could be some heavy discounts to consider, especially as more states head toward legalization.

In fact, a state that no one thought would have legalized medical marijuana, has now been discussing expanding it’s current marijuana rules to include additional diseases to treat. The New York State Health Department announced a series of changes in their medical cannabis program that is expected to increase patient access in more rural parts of the state. The state’s Health Department will add chronic pain as a qualifying condition, effective March 22nd.

So with a speculative market in place already, what are some of the marijuana stocks to be watching after the sectors recent consolidation?

As far as medical marijuana is concerned, studies have shown that many patients actually prefer it to prescription drugs. In an article from the site writes that, “Research published in the International Journal of Drug Policy has discovered that people taking psychoactive medications and drugs for conditions such as chronic pain seem to prefer medical cannabis to other drugs, including sedatives, opioids, and antidepressants.”

Several cannabis stocks that deal with pain management and even pharmaceutical applications could something to pay attention to. Ubiquitech Inc. (UBQU) through its subsidiary, HempLife Today™ focuses on CBD’s. This substance has been linked to having positive effects on people with chronic pain and even neurological diseases like epilepsy. The company itself has a large product suite that includes oils, tablets, tinctures, and more. The stock, like many others in the space, pulled back from previous highs of $0.04 (levels it hadn’t seen since May of 2016). New guidance from the company shows expectations that Ubiquitech could see an increase in their revenue for the quarter, by over 50% for the period ending Feb. 28th, according to recent press. The company recently came off of a strong year with annual revenues coming in just under $3.5million and realizing an earnings increase of 840% from the previous year in 2015. Further guidance for 2017 also shows favorable growth for the company as stated in a March 23rd announcement.

Vitality Biopharma (VBIO) has pulled back from previous highs in December. Recently trading activity, however, has the stock trading in more of a sideways pattern. The company focuses on “prodrug pharmaceuticals” that utilize cannabinoids for the treatment of serious neurological and inflammatory disorders.

In December, the company announced that it had obtained DEA approval for its research and development facilities in California. As a recent follow-up, Vitality announced that it has also completed preclinical pharmacokinetics studies with its proprietary THC glycosides in order to analyze their bioavailability. “This new drug opens up novel opportunities for treatment of pain and inflammation,” said Dr. Brandon Zipp, Director of R&D at Vitality. “We can now exploit the cannabinoid receptor system without systemic THC that compromises cognitive function.” Robert Brooke, CEO of Vitality, adds that, “It is THC without the high and could be a game changer, especially for treatment of indications like Crohn’s disease and for use in children.”

Rocky Mountain High Brands (RMHB), a company focused on the beverage business, has mimicked a similar move after pulling back from highs of $0.164 in January. Products under the brand include several hemp infused drinks targeting energy drink consumers, relaxation drink consumers, and those interested in bottled water as well. Recently the company announced that it has entered into an agreement with L and H Resort Systems to acquire a former Catskill Mountain resort facility located on a natural spring.

According to the company, the plan is to repurpose the resort into a Bottling and Canning Plant for Rocky Mountain High Brands. A few weeks back, control of the company changed via a share purchase from the company’s previous controlling shareholder. Details of this can be found in an 8K filing. Though the stock has pulled back, this is seemingly par for the course of the industry. Recent trading sessions show shares of Rocky Mountain have been relatively unchanged after trading between $0.078 and $0.087.

Axim Biotech (AXIM) have steadily begun to recover after “the great marijuana stock pull-back.” At one point the stock was trading as high as $19.80 and ended up consolidating to as low as $8.01 in February. The company’s flagship products include CanChew®, which is a CBD-based chewing gum, and MedChew Rx, a combination CBD/THC gum that is undergoing clinical trials for the treatment of pain and spasticity that deal with multiple sclerosis. In recent news, Axim announced that it has retained a contract research organization, Ora®, Inc., to take care of the company’s pending product development and clinical trials for the treatment of glaucoma and dry eye. The company will be utilizing cannabinoid-based therapeutics

Since trading around $0.025 in September, mCig, Inc. (MCIG) has managed to reach highs of $0.505 within the last few months but yet again, as with many other stocks in the sector, shares have pulled back in price and recent trading has seen the trend as more sideways than anything.  The stock has been upholding a channel roughly between $0.200 and $0.30 for the last few weeks. The company most recently announced that it has been selected to be the builder of choice of the first large scale indoor grow facility in Oregon for Forest Grove Cultivation. According to the company, the project will generate a minimum $1.5M in revenue for the Company, but could exceed $1.9M with add-ons.

But this trend hasn’t just impacted US-based public cannabis companies either and with that, the timing for international stocks headquartered in Canada could also be something to keep a close eye on. This is also in consideration of the country’s pending legalization. A few of these consolidating Canadian marijuana stocks include Canopy Growth Corp (TSE:WEED) (OTC:TWMJF), OrganiGram Holdings (CVE:OGI)(OTC:OGRMF), Aurora Cannabis Inc. (TSXV: ACB) (OTC: ACBFF), and Aphria, Inc. (APH.V) (OTC:APHQF).

The major takeaways for investors are to keep in mind that the market for marijuana and cannabis stocks has seen a period of consolidation, which followed previous statements made by certain officials. However, recent sentiment and statements made further by some of the same parties could support a more favorable stance on the topic. In the end, though many of these stocks saw a first quarter high, the general pullback, industry-wide, could be signaling investors to be on the lookout for the next sector catalyst to spark another bull move.


Marijuana Trends: Is CBD The Next Big Focus?

There’s been no confusion about the topic. Marijuana legalization has enlightened the masses. This hasn’t been just from a recreational “get high” stance but also from medicinal applications as well. One of the key substances that many in the medical community focus on has been cannabidiol or CBD for short. This is one of at least 113 active cannabinoids identified in cannabis. It is a major phytocannabinoid, accounting for up to 40% of the plant’s extract. But why is it important and why will it be something to pay attention to during the birth of this new marijuana / cannabis industry?

When cannabis is consumed, cannabinoids bind to receptor sites throughout our brain (receptors called CB-1) and body (CB-2). Different cannabinoids have different effects depending on which receptors they bind to. For example, THC binds to receptors in the brain whereas CBN (cannabinol) has a strong affinity for CB-2 receptors located throughout the body. By aiming the right cannabinoid at the right receptors, different types of relief are achievable.

So what could this mean for the potential in a heavily dominated, big pharma world? Well, in short, think about the business of prescription drugs. You’ve got treatments to ease pain, treatments to fight inflammation, treatments to curb seizures, and even different therapies for combating the side-effects of the side-effects of certain therapies…and it all boils down to a multi-billion dollar industry that has proven to eventually get patients hooked on the medications; unable to get off of them due to the bodies affinity for addiction.

Cannabis could actually change this completely and there’s now a huge push by biotech driven companies and holistic users to be first in the race to tackle some of the most unique issues the pharmacological world faces right now. The rising cost of healthcare and prescription medication has basically paved the way for cannabis & CBD-centric companies to take advantage of this in a major way. In many cases, because CBD can be derived from hemp, there’s no psychoactive reaction to its use.

This having been said, let’s take a look at a few companies in the space and observe the true potential of this industry.

INMED PHARMACEUTIC COM NPV (OTCMKTS:IMLFF) has been one of the key companies in the research and development space for Cannabinoids. As one of very first biotech companies that entered the Cannabinoid research space, they could be uniquely positioned to capitalize on the anticipated growth of the cannabis-derived pharmaceutical market by creating not just therapies, but efficient scientific procedures to develop those drugs. More importantly, they may also patent new methods in the process that are bankable & universal for other companies. The company’s Chief Medical Officer, Dr. Ado Muhammed is the former Assoc. Medical Director for GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH) and was part of the development team that developed Sativex; a cannabinoid-based drug for MS that has been approved in over 15 countries worldwide.

Shares of this company have been on the rise for the last week. In fact since March 24, the price has risen from around 29 cents to as high as $0.72 on Thursday April 6. This move of over 100% within days has been catalized by INMED PHARMACEUTIC COM NPV (OTCMKTS:IMLFF) ‘s execution on its business plan.

Another company that is more in the general retail/over-the-counter market is Ubiquitech Software Corp (OTCMKTS:UBQU). Don’t let the name fool you because through their subsidiary, HempLife Today, they procure and sell their own line of CBD products under the “CannazAll” name-brand. Recent guidance suggests that the company is on pace for a banner year. In fact, the CEO himself (James Ballas) stated in a recent press release, “”With the quality of our products, our marketing, customer support and satisfaction, and our dynamic thinking, we will continue this growth through 2017 and into 2018, which we are already planning big things for, and this is the thinking that will take our revenues to even higher gains as we continue.”

Additionally, those who may not be familiar with CDB products have been given a chance to get a free sample. On Thursday, Ubiquitech Software Corp (OTCMKTS:UBQU) announced that it would be giving away a free trial pack of six CannazALL™ CBD GelCaps to all existing shareholders, their families and friends. Similar to InMed, the company’s stock has coincided with the rise in CBD stocks. Since March 30, shares have increased by as much as 26% during the week of April 2.

Another CBD stock to watch is Cara Therapeutics Inc (NASDAQ:CARA). This has actually been a stock mentioned by CNBC host Jim Cramer. It’s estimated that between 26 and 36 million people abuse opioids worldwide. As the problem becomes more pronounced, Jim Cramer spoke with the CEO of a company that hopes to help solve the epidemic. Cara Therapeutics Inc (NASDAQ:CARA) has been steadily climbing since December and the stock price has managed to skyrocket by 105% ($9-$18.50). Their recent expansions into the pain-relief industry could become a huge catalyst for their growth, especially as the market starts to accept CBD as a healthier alternative to addictive opiate-based painkillers.

Other companies that are in this arena helping to pave the way for new options of pain management (and related) include GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH), Zynerba Pharmaceuticals Inc (NASDAQ:ZYNE), Insys Therapeutics Inc (NASDAQ:INSY) and Cannabis Sativa Inc (OTCMKTS:CBDS).

Marijuana Stocks To Watch 2017

Marijuana Stocks To Watch 2017

Earlier this year covered the market for marijuana stocks post Trump and many of these marijuana stocks have continued to see progress over the time since. Now that we’re finally through the transitional period, it’s time to look ahead at marijuana stocks to watch in 2017 and even beyond. Who would have thought this industry would have come this far, let alone open up the doors to an entirely new and evolving sector.

Marijuana stocks leaf.jpg

In fact, according to new research, North American sales are projected to top $20.2 billion by 2021. Marijuana sales in North America grew by an unprecedented 30% in 2016 to $6.7 billion as the legal market expands in the U.S. and Canada, according to a report from Arcview Market Research. So, it’s hard not to find the best marijuana stocks to watch this year and in the years to come.  Several we have watched, mentioned, reported on, and reviewed very recently with favorable market activity in play.

First and foremost, mCig, Inc. (MCIG) is a company had watch grow immensely over the last few months.  Since it was trading around 2 and a half cents in September, MCIG has seen highs of as much as $0.505.  The stock has been upholding a channel roughly between $0.30 and $0.40 for the last few weeks and multiple announcements show, in our opinion, that company’s focus on really building shareholder value including triple digit sales growth, canceling 20 million shares  and converting another 60 million shares into preferred that also carry with it a 2 year lock up.  The company has also announced that it will be reporting on its “record financial growth numbers and cost basis investments; to include, Vapolution, VitaCBD, Omni Health (OTC PINK: OMHE,) Agri-Contractors, and other strategic partnerships.”

The Green Organic Dutchman Holdings Ltd. (TGOD) comes onto this list following the roll-out of our previous coverage on now public company, Emblem Corp (EMMBF). Emblem was one of the most anticipated offerings that has come out of Canada in the last few months.  For TGOD, besides being licensed under the access to cannabis for medical purposes regulations (ACMPR) to cultivate medical marijuana, TGOD has some big names behind it from a financing front including familiar faces from the Emblem & Organigram camps.

In addition to this, the company has 1,000 kg current annual indoor operating capacity as well as a newly acquired property coming in at 75 acres, which adjoins the current facility. The planned IPO of TGOD is in October, more details here. looked at OWC Pharmaceutical Research Corp.  (OWCP).  This was trading around $0.95 and recent trading activity has seen this hit as high as $3.23.  The company has most recently been adding to its advisory board.  Both Dr. Sharon Rozenblat and Ms. Miriam Sani, MSc Eng. Dr. Rozenblat will be overseeing the completion of the pre-clinical safety studies on the Company’s treatment for psoriasis, which commenced in November 2016 and Sani is the CEO and owner of “Shefa Amirim” Ltd, which provides regulatory affairs and clinical consultation services for early-stage start-ups in various medical fields. The company itself focuses on two things: 1. medical research and clinical trials to develop cannabis-based pharmaceuticals and treatments for conditions including multiple myeloma, psoriasis, fibromyalgia, PTSD, and migraines and 2. OWCP is developing unique delivery systems for the effective delivery and dosage of medical cannabis.

Rocky Mountain High Brands (RMHB) is another company has watched since the days it was called Totally Hemp Crazy and ever since, this company has been able to grab attention of the market.  The company specialized in hemp infused beverages and more recently an alkaline water called Eagle Spirit, which was issued a trademark on Feb 22. Aside from this, the company has been implementing a partnership strategy, enhancing its internal fulfillment operations, as well as making it a known presence at industry conventions.  As of Wednesday 2-22-2017, shares of Rocky Mountain High had hit highs of $0.118.

Advantis Corp. (ADVT) was a company started watching last summer and since the beginning of the year, picked back up on it.  There’s enough going on here in our opinion to take notice of including the recent announcements that the company has taken steps to become a fully-reporting public company as well as launched distribution of topical cannabis roll-on and Tinctures to treat pain conditions. This also comes as the company has begun to further expand on its overall product offering so just like cited at first “way back when” with Totally Hemp Crazy, contributors at think that ADVT could be another company to follow during its infancy.  Since picked back up on this, also watched as ADVT climbed from around $0.005 to highs of $0.035 during the last full week of February.

UbiquiTECH Software Corp. (UBQU) was another company mentioned a few months ago and saw it promptly run from under $0.015 to highs of $0.04.  Of course the market saw pull back but now the new price channel might be hovering closer to 0.02 than 0.01 where it was at late last year.  Fundamentally speaking, the company has announced several new CBD products, paying down thousands of dollars in debt, as well as realizing significant revenue growth of 35% as well as an increase in earnings of 840% compared to that of 2015.  Compared to the company’s annual revenue of $3,493,113, UBQU saw a recognizable jump from the 4th quarter were 35% of the company’s total revenues for the year.  Further UBQU’s last 3 quarters leading up to the most recent filing show quarter over quarter revenue growth and report a net income for the year of over $330,000

Aurora Cannabis Inc. (TSXV: ACB) (OTCQB: ACBFF) made our list a few months ago and it has kept its spot especially considering the move for Canada’s legalization. The company’s wholly-owned subsidiary, Aurora Cannabis Enterprises Inc., is a licensed producer of medical cannabis pursuant to Health Canada’s Access to Cannabis for Medical Purposes Regulations and operates a 55,200 square foot, expandable, state-of-the-art production facility in Mountain View County, Alberta, Canada. In addition to partnership and collaboration deals with the like of companies like Radient Technologies (RTI.V), this company has also obtained significant financial contributions through its bought deal private placement with a syndicate of underwriters led by Canaccord Genuity Corp. for aggregate gross proceeds to Aurora of $60,007,500.

Other Canadian marijuana stocks to watch include Canopy Growth (WEED.TO), which just announced that it has entered into a memorandum of understanding with Namaste Technologies Inc. “to define the intention of Namaste and Canopy to expand their respective market positions by seeking to form multi-point working arrangements and exploring the development of new delivery devices for the consumption of cannabis.”

Namaste’s database consists of approximately 300,000 customers that generate upwards of 600,000 site visits monthly. Namaste also has 26 e-commerce retail stores in 20 countries. We watch now in the midst of all of the developments as Canopy has grown from a stock trading under $3 to today’s price of more than $12/share.

Future Farm (CSE: FFT) (OTCQB: FFRMF) formerly AGSTF, this company is something covered from very early on.  This company has been aggressively expanding into the marijuana space.  The Company’s business model includes developing and acquiring technologies that will position it as a leader in the evolution of Controlled Environment Agriculture (CEA) for the global production of various types of plants. Future Farm provides scalable, indoor CEA systems that utilize minimal land, water and energy regardless of climate, location or time of year and are customized to grow an abundance of crops close to consumers, therefore minimizing food miles and its impact to the environment. began following this at $0.137 and this week it has managed to hit highs of $0.50; a solid run of 265% so far and could certainly be something to be watching into 2017.

Similar to Aurora, Aphria, Inc. (APH.V) (APHQF) has entered into an agreement with Clarus Securities to which the Underwriters have agreed to purchase, on a “bought deal” basis, 10,000,000 Common Shares of the Company at a price of C$5.00 per Common Share for aggregate gross proceeds to the Company of C$50,000,000. This is expected to close on or about February 24 of this year. The company also recently received approval to jump from the TSX Venture Exchange to list on the TSX and depending on meeting certain conditions, is expected to be finalized on or before the TSX imposed May 3rd, 2017 deadline. The stock on the US exchange and the Canadian exchange has been on an uptrend since last March.

Original Article:

Waste Management Stocks Have Investors Cleaning Up $WM $BHTG $WCN $RSG

Original Article:


Really take a look at the historic charts of some of the biggest companies in the market right now. What sectors come to mind? Tech, biotechnology and maybe online retail are some that you think about, but did you consider garbage? Come to find out, waste management has become one of the biggest businesses on the planet and is projected to grow to over $1.4 trillion in annual revenue by 2019.

Of course, there are municipal services and private sector organizations, but some of the largest companies within the arena are publicly traded. A look at some of the chart patterns has not only raised my eyebrows, but many investors as well.

Take for instance, Waste Management Inc. (WM), the largest public waste management company. It did roughly $13 billion in revenue last year and continues to expand on its collection and landfill operations. Nearly all of its revenue came from these two areas alone.

Year over year, the company increased revenue from collection operations by 4.3%. It also saw a 6.5% increase in revenues from landfill operations compared to 2015. Although these figures are positive on an annual basis, they are still down from the near $14 billion the company did in 2014.

View photos

Since last March, the stock has increased from lows of $55.11 to as high as $73.20 as of the morning of Feb.21.

Similarly, Republic Services (RSG) recorded 88% of its over $9 billion in annual revenue from just collection and landfill services. The company cleaned up with a 4% increase in year-over-year fourth-quarter revenue, and its adjusted EPS went from 50 cents to 57 cents, a 14% change from the fourth quarter of 2015.

In a statement, Republic Services CEO Donald W. Slager explained his stance on continued growth for the company into 2017.

“We finished the year strong and delivered fourth-quarter and full-year results that exceeded the upper end of our guidance,” Slager said. “Our positive momentum continued throughout 2016, which resulted in full-year margin expansion, high-single-digit earnings and free cash flow growth, and improved return on invested capital. Our solid results continue to reflect positive contributions from reinvesting back into the business and successfully executing our strategy of profitable growth through differentiation.”

Further guidance on 2017’s operations also has the company slated for revenue growth of 4.5% to 5% in addition to expanding its margins by 20 to 40 basis points to a range of 28.5% to 28.7%. The direction the company has taken seems to be resonating with investors as the stock is up nearly 36% since last March.

View photos

When you consider the market has been considerably bullish overall, stocks in this sector have been able to outperform the S&P 500 during the same time frame. Look at the SPDR S&P 500 ETF (SPY). Alhough it has seen roughly a 25% bump since last March, it still pales in comparison to stocks in this sector.

View photos

But it is not just about trying to do the same things big companies like Waste Management and Republic Services are doing, with the hopes of grabbing a piece of the market share. Other companies like BioHiTech Global (BHTG) are looking to reinvent what it means to dispose of organic waste. The company specializes in a “tech meets waste management” scenario.

Its flagship Eco-Safe Digester actually uses aerobic digestion technology to knock out food waste at its origin. This technology utilizes microorganisms and oxygen to safely and quickly break down food waste. It then discharges it to a standard sewer line. The system is also directly connected to the company’s BioHiTech Cloud. This collects real-time operational data from the Eco-Safe Digester, giving clients the ability to remotely analyze and react to certain changes.

Essentially, BioHiTech has the ability to replace a dumpster in the back of a restaurant and substitute its digester system to break down things like meat, fish, bakery goods, dairy products and a myriad of other items.

Similar to Republic Services and Waste Management, BioHiTech has also realized annual revenue growth. For the nine months ended Sept. 30, 2016, the company recorded an increase of 63.8% compared to the same period in 2015. Gross margins also jumped from 9.6% in 2015 to 25.7% for the same period in 2016. This growth was a result of a dramatic increases in both equipment sales (up 293.7%) and rentals (up 37.2%). A recent series of announcements revealed the company’s inclusion of new leadership from people like former Wal-Mart (WMT) Senior Vice President Anthony Fuller.

In addition to the aforementioned waste management stocks, Waste Connections Inc.(WCN) has also followed a growth pattern and recently hit new 52-week highs of $84.34 as of Feb. 21. They, along with BioHiTech, will be presenting at the upcoming Waste and Environmental Services Symposium hosted by Gabelli & Company.The company released earnings after the market closed on Feb. 21. Expectations were high from several street analysts, including Zacks Equity Research.

View photos

“Waste Connections outperformed the Zacks categorized Waste Removal Services industry with an average return of 7.5%, compared with 7% for the latter, over of the last three months. With prime location of disposal sites within competitive markets, Waste Connections has optimal asset positioning to generate higher profitability.”

Leading into the next corporate filings, Waste Connections’ nine months ended Sept. 30, 2016, showed a favorable increase in both revenue and margin of operating income on a year-over-year basis between 2015 and 2016. Revenue jumped from $1.59 billion to $2.33 billion and operating income went from a deficit of $163 million to a surplus of $313 million. Increased margins were aided by the company’s decrease in “impairments and other operating items,” which went from $494 million for the nine-month period in 2015 to less than $4.7 million in 2016.


It would appear the waste management industry could be set to continue seeing growth as the market is anticipating it to be valued at over $1.4 trillion in the very near future. Consideration of the actions taken by the Trump administration for things like deregulation of certain sectors does not seem to have made this market waiver in the least.

Furthermore, many companies involved have demonstrated consistent growth year over year, and with no shortage of humans contributing to the creation of waste, it would seem this sector would be positioned to benefit from the growing global population. Further innovation has also built interest as more “green” alternatives to simple garbage management could be creating a new niche to waste management.

Disclaimer: The author owns zero shares in any companies mentioned within this article. The author is affiliated with Midam Ventures LLC a company which has an exisiting marketing & awareness contract with a non-affiliate third party Woodgrove Enterprise to provide marketing & awareness for BioHiTech Global (BHTG). The author has not been compensated to write this article.

Original Article here:

Another Day Another $DOLLAR…or Thousand(s)!

I missed Monday but what can I say, it’s been friggin’ BUSY in the markets.  Whoever said sell in May and go away obviously hates making money because day after day there seems to be a brand new unicorn trade…or at least the beginning of a multi-day unicorn.  Today I absolutely killed it with SPHS, which I entered on Friday and made sure to mention it in detail.  Entry into this one was confirmed Friday afternoon after I had stalked the crap out of it for most of the day.  My entry was a little high for that day but after holding into Tuesday, I have no complaints!  Highs of $8.55…YES PLEASE and thanks to a nice liquid market, my average price on the exit was great at $8.17.

Screen Shot 2016-07-26 at 3.44.27 PM

As far as the other Friday trades, CLNT topped out at $1.80 again Tuesday so I probably could have gotten out of it on Friday.  I’m still content here with modest gains but out of the market there (for now).  It’s gotten real choppy so until I can ID a consistent pattern, I’m gunna shy away…again…for now.

ZFGN I’m still long on and progress in the market isn’t as aggressive but I’m fine with that.  I don’t need to monitory this one every second…more like every minute so the $2.99 entry isn’t doing too bad for me right now with ZFGN sitting around $3.10.  My hope with this trade is that the gap down from a few weeks ago starts to fill and I feel like a news catalyst would be good here. The company focuses on obesity and has early Phase Trials going on.

As far as NFEC, NSPR, WHLR, or GDEE go, I missed the quick spike on NFEC and I’m happy I did because the stock consolidated for now and I’m watching to see if it goes any lower or back to that previous support it was trading at before the jump. NSPR was the same and honestly this one…just in my opinion…may not have a whole lot of percentage potential on a single day.  The shares structure is pretty large including the float. If you look at a candlestick chart you will notice like I did, NSPR only moved from $0.1946 to about $0.22 the day it traded almost 16million shares.  What could that mean?  Well in my mind if it took that many shares to see just a small increase, how much will it really take to see the kind of gains I really want?  But…I’ll keep it on watch for now. WHLR I need one more day to watch but the chart is really looking good in my opinion.  It’s climbed steadily and no major red days to speak of (yet).  GDEE, a previous promotion, is still trending at the bottom of its chart and if there is no promotion, organic market momentum could be something excited as a potential catalyst.  Again..still on watch.

So What Else?

Well, today’s trades were VERY EXCITING and an old time long of mine is going bonkers right now.  I entered at about $0.84 a few months back, exited the majority of my position late last month and ended up re-entering again at the beginning of this month.  I took profit because I wanted to get some cash free in my account to make new trades but if I didn’t do that, my total position would be awesome right now.  Either way I’m not unhappy whatsoever…What’s the symbol?  EBIO of course and my @SobeDayTraders Instagram post shows exactly the entry.

Screen Shot 2016-07-26 at 3.38.17 PM

When I have time, I’ll pretty up my posts and put em up on Instagram but lately the market’s been soo busy, I just haven’t had time…I will try to do better (my twitter is more active).

ALIM was another trade I went long on today.  I probably should have sold the majority of my position but I’m taking a gamble on an overnight hold.  The chart held itself together all afternoon so I’m hoping to see another leg to this climb. They just came off of a record second quarter and could have been the spark to this move today.

Screen Shot 2016-07-26 at 4.07.22 PM

My only day trade today was also pretty amazing. KOOL was something I was looking at and probably should have gotten into yesterday afternoon but I just didn’t think it would hold the trend.  “Listen to your Gut Small Cap!” Anyway, this morning I decided to tuck my nuts up and just go for it during the first hour and a half of the trading day.  I pulled off a $4.75 entry  and managed to grab a decent gain on a $6.16 exit from most of my position right when it started to pull-back the second time during the afternoon.

Most likely I’ll keep it on watch during the post market hours because even though it did consolidate this afternoon, I saw no real catalyst to this type of “All Day Move”…someone know something I don’t?  So I may take another toe dip tomorrow and add to what I have left as a very small core…we’ll see.  I like speculative plays but I also really like high risk 🙂

Screen Shot 2016-07-26 at 3.34.09 PM

WGBS I may have been a bit pre-mature here but I ended up grabbing a small position right at a Buck this morning.  It’s pulled back a little bit but overall I really like the daily chart on this.  Volume is building and price is maintaining a bullish direction. The crazy part is that they haven’t had news in quite a long time so I’m wondering if anything is rumored here.  If anyone has any spec on this one, leave something in the comments for me.

My shining star this week, however, has been INNV.  I know you shouldn’t fall in love with stocks…and I’m not saying I do…but the chart and volume on this one have both been amazing.  My entry was right at the open on Monday so my base is solid at $0.455 and I’ve only taken a small haircut from my position, taking profit on a quarter of my whole position when INNV hit $0.64.  There’s a lot of speculation on the pending results of their FDA submission and from what I’ve seen they are supposed to find results sometime between here and September.

Screen Shot 2016-07-26 at 4.28.01 PM

Either way, it could be exciting so I’ll most likely trade around my core until something out of the ordinary (research report, way above average volume, or something along those lines) happens.  I’ve got a good core so I’m setting an initial stop at $0.54 (just in case I take my eyes off the screen and something happens). I also saw a promotion on it as well and it looks like whatever size of that network, it looks active so thanks for the awareness haha! I also shamelessly plugged the article from Friday because…why not pound the chest a little…It was a “Great F*cking Friday” lol.

Well, that’s all I have for now.  Keep up the great work and everyone who’s sending me DM’s keep em coming.  I’m all about interacting with everyone following along…AND REMEMBER:

Disclaimer: I’m not paid to advertise any of these companies and you should only take what I say for entertainment purposes only.  If you are concerned about making money in the market DO NOT TAKE MY ADVICE.  CONSULT A REGISTERED FINANCIAL ADVISOR for any trade or investment related actions.  I’m not licensed and if I lose, I’m losing my own money.  I am in no way responsible for anyone making their own mistakes. Also I may be buying and or selling during the time I mention these stocks.


What’s there to say today? Earlier this morning I tweaked some things on a few of the scanners that I built on the E*Trade Pro platform and long story short, I caught some of the biggest swings in price than I have ever hit in a long time.  Usually the scanners, how they were set up, would catch on DURING a move and I’d miss out on some serious profit.  Not even money left on the table but simple money not PUT on the table at all.

Needless to say, today has been phenomenal and usually I’m more of a swing trader than anything.  Today though, my day trade skills were tested as well as the new scan set-up I put together.  Even though I risked a decent amount of money, it was all in the name of learning and trying to stream line what already has been working.  So what was today like?

Screen Shot 2016-07-22 at 12.26.26 PM

Ended up taking a long position in ZFGN.  Haven’t really read up on the company yet but what I have done is analyze the chart set-up.  Lately there has been a pretty successful trend of finding Gap Down charts and playing the speculation.  Miss most of the downside after it finds bottom and if we see some speculative trading like today, my outlook is simply based on the idea that there have been a TON of biotech stocks that have had a similar pattern and enough spec on “future” potential of their drug therapies has been enough to ignite a decent run.  Obviously I’m taking HUGE caution here because as speculation goes, I could also lose big too. (more details to follow in the coming days)

Screen Shot 2016-07-22 at 12.31.33 PM

A couple things that hit my scanner before 11AM and GBR is the one I ended up jumping on earlier in the morning.  I try to keep my tweets as active as my trades but sometimes it’s difficult.  In any case GBR entry was at $3.04when the stock was seeing a lot of above average volume while also holding a sideways pattern.  My hopes were that there was enough short interest to catch a squeeze and sure enough that’s what I think we saw.  GBR ended up hitting a high of $5.13.  I wasn’t lucky enough to get out at the high but a $4.40 exit after it started to pull-back isn’t too shabby in my book either 🙂  As far as INVT, I never entered the trade.  It was way too volatile for me and rightfully so it has ended up coming down in price.  KONE was something I traded yesterday on some monster momentum and wished I had held out a little more for an overnight hold.  Unfortunately my balls are THAT big so I took a 45% gain on it intra-day on Thursday LOL.

Screen Shot 2016-07-22 at 12.36.56 PM

CLNT was another great trade so far today.  I took a shot at it with a small starter at $1.30 and still holding (as of 12:38PM EST).  I’ll keep a close eye on this during the afternoon and if I reeeaaaaly like what I see, I may overnight hold here.  NFEC I have on watch.  The daily chart looks good to me and I’m hoping to see a confirmation of a new bull trend.  Kaikin Ashi (or however you spell it) chart shows a bullish undertone so for now it’s on my watchlist for a swing.  NSPR is the same as NFEC.  I’m not in it but again the daily chart looks a lot better over the last two days, there haven’t been any crazy moves like GBR or XCOM on an intra-day level so this may be as simple as a bottom bull play. And as far as OPGN goes, I thought about trading this today but the intra-day chart has consolidated on me before I could make a decision to react.  I would probably be in the red by a little bit had I taken the plunge so right now it joins the party with NFEC and NSPR on my watchlist

This slideshow requires JavaScript.

SPHS is a bit of a different story because it has had an AWESOME day so far with really nice volume that has taken the stock from about $3.90 to $4.60 and is now trading kinda sideways.  If you look at the DAILY chart though (slideshow above) I notice that even though volume is a little light compared to the explosion it saw a few days ago, the stock is continuing to increase steadily in price.  For me this is still a watch BUT depending on what the afternoon looks like and possibly what Monday (7.25) looks like, this may be something I bring home with me for a few days.  I will be watching to see if it retraces back to the 20MA (yellow line) or if it can establish a new channel a bit higher that the 20 to potentially retrace back to.

This slideshow requires JavaScript.

LPTN is another one on the list.  We’re starting to see an uptick in volume while price has just started to increase.  In my opinion, just like CBYL….just like MRNS, this could be the early signs for a reversal in my opinion. So for now, LPTN is on watch.

Other than these, I’m watching a few others that have charts that  I feel could indicate some kind of promotion or at the very least, “nudged continuation trend” WHLR, GDEE, and CJJD:

This slideshow requires JavaScript.


They’ve got these chart patterns and volume indications that I like to see when I’m targeting a swing.  Quiet to moderate volume, consistent price movement on a gradual basis, and testing technical end points like Moving Averages and historic Support/Resistance lines. That’s all I’ve got right now. If you come across this article and want to follow me live, head to twitter and follow @MrSmallCap a/k/a  Small Cap Reporter…and if you wanna be really awesome, share this and get your friends to follow the twitter handle.  Have a great weekend!


Disclaimer: I’m not paid to advertise any of these companies and you should only take what I say for entertainment purposes only.  If you are concerned about making money in the market DO NOT TAKE MY ADVICE.  CONSULT A REGISTERED FINANCIAL ADVISOR for any trade or investment related actions.  I’m not licensed and if I lose, I’m losing my own money.  I am in no way responsible for anyone making their own mistakes. Also I may be buying and or selling during the time I mention these stocks.




Why Should Investors Be Paying Attention To Software As A Service? International Business Machines Corp. (NYSE:IBM), Oracle Corporation (NYSE:ORCL), Iddriven Inc (OTCMKTS:IDDR), & Microsoft Corporation (NASDAQ:MSFT

Global “Software as a Service” (SaaS) revenue is expected to increase more than 20% year over year to a whopping $106 billion in 2016 according to Goldman Sachs, with North America accounting for a significant share of the market as they prove a widespread use of SaaS apps across a variety of verticals. The dynamics of the company create opportunities for small, agile companies to build their market share and expand. International markets, though, may see the highest growth rates moving forward. SaaS security applications enable IT to eliminate a good deal of on-premises hardware and software. This facilitates the process by cutting out the need for a big upfront investment right off the bat. We’ll discuss how companies like International Business Machines Corp. (NYSE:IBM)Oracle Corporation (NYSE:ORCL), Iddriven Inc (OTCMKTS:IDDR), and Microsoft Corporation (NASDAQ:MSFT).

Implementing SaaS also takes away the need for unnecessary upgrades and new implementations. Instead, all the hardware and software are managed by your security SaaS provider, behind the scenes. Others aim to completely take over the end-to-end management of your applications and data. According to a 2016 report on the state of SaaS-based security, 1,400 have popped up in the past five years alone, with subscriptions for IT, business intelligence, enterprise vertical applications and SaaS-based security continuing on a rise.

Software as a Service has grown to become the latest trend within the business world, making buying and installing programs onto a computer a thing of the past. Given the growth of this software licensing and delivery model, it is important to get a grip on what is trending. As of 2016, according to, 81 percent of the surveyed companies got a maximum of 20 percent of new revenue from existing customers in the form of upselling and expansion sales. SaaS companies with a faster growth have better results in terms of churn and upsell, a trend that has been concluded accurately over the past two years. Over 50% of companies surveyed in a recent MarketsandMarkets research report assigned the biggest portion of their budget for customer retention costs, with an increasing focus on the ideas of focusing on building teams rather than on developing their infrastructure.

The SaaS market is still in its infancy and proves to hold maximum potential for future growth as businesses move towards a cloud-based system. Public markets are currently valuing SaaS businesses at about 4.5 times run rate revenue. The identity and access management (IAM) market are expected to grow from USD 7.20 Billion in 2015 to USD 12.78 Billion by 2020, at a Compound Annual Growth Rate (CAGR) of 12.2% during the forecast period, according to the same MarketsandMarkets survey. Growing emphasis on management, increasing mobility trends, telecommunications, public, and critical infrastructure sectors are the main drivers driving the growth in identity and access management market.

SaaS is becoming increasingly popular, and as the industry develops, more and more companies are dropping their traditional business models and moving in favor of these new technology solutions. One of the benefits of the SaaS model are that it is easier to administrate, all users will have the same version of the software because updates will be done automatically, and therefore collaboration will be made easier.

Also, it will grant global accessibility, making remote work models easier, which helps in reducing costs as well as in improving performance. As more and more SaaS products are integrating marketplace dynamics into their business models, the prevalence of these products is becoming a necessity for further expansion of their companies. Instead of companies installing software on their own servers, software providers host the software at theirs and charge them according to the time they spent using it, for a simple monthly fee. Identity Access Management is a framework for business processes that facilitates the management of electronic identities. The framework includes the technology needed to support identity management. This technology can be utilized to initiate, capture, and manage user identities and their related access permissions in an automated manner.

Thus, this ensures that access privileges are granted according to one interpretation of policy and all individuals and services are properly authenticated and authorized. With the ever-evolving business environment, it can become difficult to keep track of as employees migrate through different roles in an organization, while also managing identity and access. While North America had captured the largest market share in 2015 for IAM, Asia-Pacific is the fastest growing region in terms of CAGR. Factors that affect a company’s decisions to switch to the innovative cloud-based business model for IAM solutions are increasing internet usage, compliance regulation, and mobile usage.

An increasing number of enterprises and industries are spearheading the technology implementation in terms of mobility, cloud computing, hosting services for a variety of sources, leading to increased customer base and internet users, leading to the surge necessity for IAM solutions. Currently, companies like International Business Machines Corp. (NYSE:IBM)Oracle Corporation (NYSE:ORCL)Microsoft Corporation (NASDAQ:MSFT), and Dell make up a significant portion of the identity and access management sector, building off of the “Software as a Service” mentality. Smaller companies have also entered the space at a time when the mergers and acquisitions climate is beginning to heat up. Companies like Iddriven Inc (OTCMKTS:IDDR) and CRM are competing for the lion’s share in the market, providing innovative solutions for day-to-day business environments. Specifically, IDdriven has recently been building its international footprint through new, leading channel partnerships that will allow for further integration of IDdriven’s IDaaS solution with Microsoft’s Identity Manager Software, thanks to interface software funded and developed by companies like Oxford Computer Group.

The trends are in favor for Identity Access Management as well as SaaS solutions, and the global surge towards a cloud-based business environment facilitates the market growth for these solutions. The new, integrated next-generation identity management platforms provide breakthrough scalability with an industry-leading suite of identity management solutions. According to an IDC study, SaaS delivery will significantly outpace traditional software product delivery, growing nearly five times faster than the traditional software market and becoming a significant driver for functional software markets.

Forecasts hold a positive outlook for these solutions, pointing to future successes, with new developments and improvements being made daily for a competitive advantage on the market. The future bodes well for SaaS and IAM solutions, with opportunities for growth as more companies move towards cloud-based environments.

$PGSC Progressive Green Solutions (OTCMKTS:PGSC) Grabbing Big Gains On Light Volume Early On Wednesday

Why Progressive Green Solutions (PGSC) is Well Positioned to Drive Shareholder Value Through Reverse Logistics

Some of the largest retailers and shippers in the business utilize reverse logistics (“RL”) to capitalize on returned items and sell these goods in a secondary market. Items that are not brand new and ones that have never been used are procured through returns or even from stores like Sears (SHLD) and Macy’s (M) to create revenue from items that were once discarded or simply liquidated at extremely low prices. According to former Best Buy CMO Barry Judge, “Secondary market electronics sales represent an estimated $15B market in the United States.” So we know this is a huge market secondary or not.

Many Fortune 500 companies like GE (GE), Amazon (AMZN) and Ebay (EBAY) are taking full advantage of what some used to call a mistake. According to a quote by Dan Eisenhuth, executive vice president for asset recovery at GENCO Distribution System, “Retailers used to liquidate to Compensate for ‘screw-ups.’ Today they do it to stay fresh.”  

How “Fresh” is Selling Damaged and Refurbished Goods?  

To put things into perspective, the value of U.S. remanufactured production grew by 15 percent to at least $43.0 billion, supporting 180,000 full-time U.S. jobs in 2011, according to the US International Trade Commission. There is no doubt that the market is getting bigger and with the DOW hitting 18,000+, new companies are sure to emerge as secondary market consumer electronic distributors and secondary appliance distributors.

The average consumer saves close to 30% for an item that has a small ding from the show room or for a scratch from moving it off a truck. For example, consumers spent $998 on average per person in 2011 for electronics and that would have been roughly a $300 savings. With more and more people spending their money wisely and with these items being “as good as new” the industry as a whole has blossomed into a great investment opportunity.

PGSC: Undiscovered Company Beginning to Increase its Footprint…Quietly

Take a look at potentially undervalued company, Progressive Green Solutions, Inc. (PGSC).  This company is deeply seeded into reverse logistics and boasts some strong numbers in its financials.  The first 6 months alone show revenues nearly hit $1million every quarter with a 20% gross margin. Total cash on hand was just over half a million dollars and total current assets nearly topped out at $2million after the close of its second quarter.   More importantly, the company has already begun streamlining operations.

First it was able to decrease COGS by adopting the capitalization of direct labor and packaging costs.  Second, the company realized an increase in gross revenue attributed to greater availability of inventory for sale and an addition to the sales team late in June 2014.  Finally, Progressive saw an increase in gross margin due mostly to a new supply chain of air conditioners (out of all potential products that could bump up numbers).  It will be interesting to see how this next quarter unfolds especially as the company continues to grow.

Due to the nature of its operational structure, Progressive has begun setting itself apart by not only focusing on building strong inventories but also enhancing how direct laborers (the “boots on the ground”) are fulfilling orders.  This is a crucial piece in the revenue model believe it or not. If operations suffer because of employees working inefficiently, the bottom line could greatly suffer.  PGSC has engaged this model to generate more revenue, increase inventories (the lifeblood to RL), decrease cost, and increase margins all within the first 2 quarters of doing business under this model.

Market Value

Right now reverse logistics has gained the attention of some of the big organizations in the retail spot and with the size of the market, a smaller player even grabbing a 5% market share could see impressive revenue numbers with shareholders reaping the benefits.  Even if you take 1% market share of a $43B industry, a company would be roughly generating $430M a year in annual revenue. For PGSC, a $430M revenue number would put this stock around $3.75 currently it’s trading at $0.70 leaving over 500% in potentially upside if Progressive’s stock ran to those highs.

As a more familiar industry, (if you aren’t up on your air-conditioning market facts) the Mobile phone industry sold about 1.2 B phones world wide last year and the return rate for that 1.2 billion was about 8% according to the Recovering Lost Profits by Improving Reverse Logistics report commissioned by UPS and written by Curtis Greve and Jerry Davis. That means that there were roughly 96 Million phones that were refurbished and then sold on the secondary market. At an average resell price of $82.50 there are certainly those who are profiting handsomely from the 7.9B that’s generated by the resale of these secondary market.


Reverse logistics is a relatively new industry having its humble beginning back in the 70’s with dry stored items being shipped to grocery stores who wanted to max their profits and not take such devastating losses. Little did the clerks and fork-lift operators know at the time that their screw ups would ultimately be a defined and studied billon dollar industry; now there could be an incredible opportunity right in front of us to take advantage of such a growing market.  Progressive Green Solutions has found an underserved niche and has continued to grow quarter over quarter as it continues to streamline its operations and feed the fire through adding to its inventories.  Simply based on its growth and revenue potential alone, this could be an incredibly undervalued company and a reason to look closely at the company especially as the third quarter is coming to a close and a new fourth quarter will be underway for the Holiday Season.

Current Market Value is Roughly $80M.  430/80 =5.375 multiple


Moko Social Media ($MOKO) Gains Attention After Latest Quarterly Review

MOKO Social Media Ltd. (NASDAQ:MOKO) is a social media digital and mobile apps platform used to compliment social media giants such as Facebook (NASDAQ:FB). The company buzz is picking up as it just released news reviewing their quarterly highlights, and MOKO extends their contract with the IMLeagues, which is used as a mobile app for Colleges and Universities’ intramural sport leagues.

The finalized structured deal between MOKO and the IMLeagues is crucial from the company’s view. By building their exclusive control of the mobile information and App rights, MOKO’s administration with IML is protected. The company can now dedicate more outlets in teaming up with IML to continue the growth of REC*ITs efficiency and further define themselves within the upper echelon of our nation’s college sports and recreation forum. MOKO is already being contacted by other media and tech businesses, as well as rights management groups, which are devoted to breaking new ground on ways to work with MOKO to achieve this “want” for the university student demographic. The new agreement with the IMLeagues also helps get rid of some obstacles and will bring initiative to expand REC*IT further than it’s current scope. This will allow MOKO to go after other deals that focus on student activities on campus and other community and adult sports and leisure management. The company is planning to release a statement pertaining to this topic in the near future.

MOKO’s Political Team is growing, its’ reach is steadily expanding and their belief is the partnership with the Netroots Nation event is a firm sign that BNR is beginning to be noticed as a major contender in digital media all throughout political areas.

One of MOKO’s goals they have stated is reaching no less than 10 million Monthly Active Users by the conclusion of 2015. Also with some of the developments mentioned above the company is speeding up its activity to achieve this goal. At the end of January, MOKO was able to attain just over 5 million MAU’s and they look to expand this during the current quarter as they release REC*IT and Speakiesy. The company’s cash burn is within their budgeted projections as they expect to receive a $1 million this quarter as MOKO’s R&D rebate. They have acknowledged and stabilized the crucial senior personnel and they are about bulk up there executive team anticipated for the next month or so.

Click Here for Full Quarterly Review

About MOKO Social Media Ltd

Moko Social Media Limited, together with its subsidiaries, engages in the digital publishing of mobile applications for youth and young adult customers. The company operates through Mobile Social, Mobile Advertising, and Mobile Commerce segments. The company provides proprietary mobile social networks and community/chat products, as well as owns proprietary mobile performance ad network for various industry sectors, such as Mobile Games, Mobile Apps, and Financial Services. It also provides digital publishing services that enable advertisers to place their ads on its properties; and mobile community development services. In addition, the company operates an e-commerce platform, which offers online and flash sales of products, as well as sells merchant products to customers. It operates in Australia, the United States, Europe, and Asia. The company was formerly known as Limited and changed its name to Moko Social Media Limited in September 2013. Moko Social Media Limited is based in Highgate, Australia.

#Superbowl of Stocks: Coming to the #OTCQB and The Year of $OXIS Continues

Coming to the OTCQB, 2015 the Year of $OXIS Continues

Oxis International (OTCQB:OXIS) has had quite the year. Right after the new year OXIS announced patent licensing for Multiple Myeloma treatments, as well as releasing press of Dr. James J Mulé to the scientific advisory board. The cherry on the sundae, so to speak, may have come last week with the announcement of OXIS being up-listed to the OTCQB.

Unless you’re new to the small cap or micro cap game, this probably isn’t the first time you’ve heard about a company getting “up-listed” and it certainly won’t be the last. Many people don’t really understand the importance of up-listing and how it can be a real game changer for the company.

There are many advantages for a company that gets up-listed but as with all good things, there are some disadvantages too. Let’s take a take a look at both sides of the coin.

Some of the advantages to a stock getting up-listed include:

  1. Exposure to more favorable financing options
  2. Increased investor confidence due to reporting requirements of the exchange
    1. IE companies need to identify an accurate share structure, list the law firm responsible for handling the company’s annual report(s), etc.
  3. Minimum prices per share will be maintained due to the requirements of the exchange
    1. For OTCQB, companies need to meet an ongoing minimum bid price test of $0.01 as of the close of business for at least one of every 30 calendar days
  4. A heightened sense of corporate responsibility by way of additional reporting by companies regarding information on officers, directors, and controlling shareholders.

If you are an investor with your eye on a company, like OXIS, that is moving up to another exchange, those are just a few of the positive things, among others.

Of course, there are also negative things to be warry of. If the company is struggling financially, coming up with the $10,000 (minimum) annual fee and one time application fee of $2,500 to upgrade to the OTCQB, could mean even more hardship for the company. Not to mention, if the company currently is already trading on the line of the minimum, it could end up having a hard time meeting the minimum price lives that are required of a company on the OTCQB.

But for those doing their DD, if the company is making the jump “the QB”, you would hope as an investor, that the company wouldn’t make that big jump if they didn’t have all their ducks in a row. For investors, the upside is, if a company they are watching is making that jump, chances are a certain level of transparency

Should exist with the company and in turn can become a strong focus for investors.


Playing with the Big Boys

Moving up can be a definite game changer for the future of a company. Establishing transparency is key in maintaining confidence of investors. Being able to have a clear picture of the financial situation of a company is one of the most important things to making smart investing decisions. And for some companies, if things go well on the OTCQB, they set their sights on the NASQAQ or NYSE!

Hopefully a Happy Ending


In conclusion, there are a host of ways a company can attract investors. From hitting today’s social media market, to hiring of a professional investor relations firm, the ultimate outcome depends on the financial health and transparency of the company in question.